There are 128 original GATT signatories, WTO Member States today are 153.
2.
Potential Impact on the US Economy and Industries of the GATT Uruguay Round Agreements. Investigations no. 332–353, Vol. I, Chapter 22, p. III-21, USITC — June 1994.
3.
Letter of Mickey Kantor (USTR) to Argentine Minister Domingo Cavallo, 14 June 1995.
4.
Office of the USTR. Designate Barshefsky announces GSP sanctions against Argentina for continuing IPR problems, press release, USTR 15 January 1997.
5.
The Need to Fix Problems in the Current System as the Best Base to Identify A System to Grant Better Access to Affordable Drugs around the World — María Fabiana Jorge in representation of CILFA and ANAFAM — WHO/WTO Secretariat Workshop on Differential Pricing and Financing of Essential Medicines, 8–11 April 2001, Hosbjor, Norway.
6.
‘Our amendment to the Trade Promotion Authority Act reinforces the Doha Declaration. The Bush administration should be using it to negotiate trade agreements that allow urgently needed access to medicines. Instead, the administration has used trade agreements to promote the interests of the pharmaceutical industry at the expense of access to drugs in developing nations. Again and again, the administration has defied the Doha Declaration and imposed unjustified restrictions on the availability of patented drugs. They've done it on trade agreements with Australia, with Jordan, with Morocco, with Singapore, and other nations. In these agreements, the Bush administration has undermined the very core of the Doha Declaration. They're trying to do it now in the Central American Free Trade Agreement’. US Senate, Congressional Record, 15 February 2005, pp. S1498–S1499.
7.
US House of Representatives. (2005) Trade agreements and access to Medications under the Bush administration. Committee on Government Reform Minority Special Investigations Division, Prepared for Rep. H. Waxman, June.
